-- 根據週二提交給澳洲證券交易所的文件，Great Boulder Resources（ASX：GBR）已獲得機構投資者和成熟投資者的認購承諾，將透過兩期配售籌集4,000萬澳元。此次配售將發行約4.706億股，每股價格為0.085澳元，較其10個交易日的成交量加權平均價格折讓近14%。 文件顯示，第一期配售預計將透過發行1.455億股籌集約1,240萬澳元，第二期配售計畫透過發行3.251億股籌集約2,760萬澳元，但需獲得股東批准。 文件也補充道，這些資金將用於支持公司從Westgold Resources（ASX：WGX）的全資子公司Aragon Resources手中收購Peak Hill金礦計畫。 該公司股價在周二的交易中上漲了19%。
Related Articles
Asia
Smartgroup Welcomes Australian Government Decision to Maintain Electric Car Discount for a Year, Shares Reach Two-Year Peak
Smartgroup (ASX:SIQ) welcomes a decision by the Australian government to maintain the electric car discount for another year, according to a Tuesday statement.It noted that the policy provides certainty for the charging industry, supporting further investment in Australia's charging infrastructure and helping build the network needed for broader electric vehicle adoption.Its shares jumped 7% in recent trading, reaching a two-year peak.
$ASX:SIQ
Asia
Market Chatter: Qantas CEO Becoming 'More Optimistic' on Fuel Supply
Qantas Airways (ASX:QAN) Chief Executive Vanessa Hudson said the company is becoming "more optimistic" on fuel supply, Bloomberg News reported Tuesday.Speaking at the Macquarie Australia Conference, Hudson said the company has fuel commitments up to the middle of June, per the report.Hudson noted that the airline registered strong demand for domestic and international air travel despite high fuel prices.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:QAN
Asia
Sigma Healthcare Says Chemist Warehouse Brand to Enter UK Under Agreement With Pharmacy Group; Shares Rise 4%
Sigma Healthcare (ASX:SIG) said Tuesday signed a memorandum of understanding with Greenlight Healthcare, under which the Chemist Warehouse brand will enter the UK market.The company said in a statement that it will acquire a 75% interest in a number of stores of the employee-owned pharmacy group, with 25% continuing to be held by GreenLight.Sigma will license the Chemist Warehouse brand and intellectual property, and provide retail support, while GreenLight will provide the dispensary and professional services requirements as well as back office support.The first phase of the joint venture will focus on rebranding and developing up to five stores initially, with the first site to be in Hoxton Street, northeast of the city of London. If the first phase proves to be successful, more stores could be developed in the second phase. The parties plan to identify existing GreenLight pharmacies and where appropriate develop or relocate these into Chemist Warehouse stores.Sigma Healthcare's shares rose nearly 4% in recent trading on Tuesday.
$ASX:SIG